Directory
>
Ted Tarasow
Ted Tarasow
Chief Technology Officer | Inscripta, Inc.
Pleasanton, California, United States
Ted Tarasow
Summary
Ted Tarasow is an accomplished Chief Technology Officer with a strong background in biotechnology and pharmaceutical research. With over two decades of experience, he has held key leadership positions in various organizations, including Inscripta and Sestina Bio, where he has driven innovation in assay development and biomarker discovery. Ted's expertise spans multiple domains, including clinical research, drug discovery, and molecular biology, making him a vital asset in advancing life sciences. He has a proven track record of translating complex scientific concepts into practical applications, particularly in FDA submissions and product launches. Ted's diverse experience also includes consulting for several biotech firms, showcasing his adaptability and strategic insight. His leadership style emphasizes collaboration and innovation, fostering environments where groundbreaking research can thrive. A graduate of California Polytechnic State University, he continues to contribute significantly to the field of biotechnology.
Ted Tarasow
Work Experience
Chief Technology Officer at
Inscripta, Inc.
December 2022 - Present
Chief Technology Officer and Founder at
Sestina Bio, LLC.
May 2020 - December 2022
Global Head Digital Biology R&D at
iCarbonX
April 2018 - March 2020
Vice President, Product Development at
Healthtell
May 2013 - April 2018
Senior Vice President, Research & Development at
Tethys Bioscience, Inc.
June 2007 - May 2013
Consultant at
January 2003 - January 2008
Director, Biosecurity & Nanosciences Laboratory at
Lawrence Livermore National Laboratory
January 2004 - January 2007
Founder, CSO & VP Chemistry at
Invenux, LLC
January 2000 - January 2003
Associate Director, Medicinal Chemistry at
Nexstar Pharmaceuticals
January 1994 - January 1999
Ted Tarasow
Education
Scripps Research
January 1990 - January 1994
California Polytechnic State University, San Luis Obispo, B.S.
January 1985 - January 1989
Frequently Asked Questions about Ted Tarasow
What is Ted Tarasow email address?
Ted Tarasow's primary email address is ***********@l5partners.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ted Tarasow work for?
Ted Tarasow is a Chief Technology Officer at Inscripta, Inc., a company specializing in Commercial physical research.
Where Ted Tarasow graduated from?
Ted Tarasow holds a degree in from Scripps Research.
How can I directly contact Ted Tarasow?
To contact Ted Tarasow directly, you can use the email address ***********@l5partners.com. Complete contact information is available upon registration with Muraena.
Who is Ted Tarasow?
Ted Tarasow is an accomplished Chief Technology Officer with a strong background in biotechnology and pharmaceutical research. With over two decades of experience, he has held key leadership positions in various organizations, including Inscripta and Sestina Bio, where he has driven innovation in assay development and biomarker discovery. Ted's expertise spans multiple domains, including clinical research, drug discovery, and molecular biology, making him a vital asset in advancing life sciences. He has a proven track record of translating complex scientific concepts into practical applications, particularly in FDA submissions and product launches. Ted's diverse experience also includes consulting for several biotech firms, showcasing his adaptability and strategic insight. His leadership style emphasizes collaboration and innovation, fostering environments where groundbreaking research can thrive. A graduate of California Polytechnic State University, he continues to contribute significantly to the field of biotechnology.
Ted`s contact details
***********@l5partners.com
********@sestinabio.com
***********@inscripta.com
Colleagues
VP of Process Sciences
Board Member
Vice President, Head of Business Development
Chief Executive Officer
Vice President Research And Development
Principal Scientist